Meta-analysis of 10 retrospective cohort studies (2,380 BRCA-mutated patients with ovarian cancer): 8% developed breast cancer after ovarian cancer; those who did had better overall survival than those with ovarian cancer only (HR 0.4657).
Meta-analysisn = 2,380
de Souza Wagner et al. Breast cancer incidence and subtype patterns among BRCA-mutated ovarian cancer patients: a systematic review and meta-analysis